via CDC
A malaria vaccine has shown promising results in early stage clinical trials, a study suggests.
Researchers found the vaccine, which is being developed in the US, protected 12 out of 15 patients from the disease, when given in high doses.
The method is unusual because it involves injecting live but weakened malaria-causing parasites directly into patients to trigger immunity.
The research is published in the journal Science.
Lead author Dr Robert Seder, from the Vaccine Research Center at the National Institutes of Health, in Maryland, said: “We were excited and thrilled by the result, but it is important that we repeat it, extend it and do it in larger numbers.”
Many bites
It has been known for several decades that exposure to mosquitoes treated with radiation can protect against malaria.
However, studies have shown that it takes more than 1,000 bites from the insects over time to build up a high level of immunity, making it an impractical method of widespread protection.
Instead, a US biotech company called Sanaria has taken lab-grown mosquitoes, irradiated them and then extracted the malaria-causing parasite (Plasmodium falciparum), all under the sterile conditions.
They are clearly very early stage trials in small numbers of volunteers, but without question we are extremely encouraged by the results”
Dr Ashley BirkettPath Malaria Vaccine Initiative
These living but weakened parasites are then counted and placed in vials, where they can then be injected directly into a patient’s bloodstream. This vaccine candidate is called PfSPZ.
To carry out the Phase-1 clinical trial, the researchers looked at a group of 57 volunteers, none of whom had had malaria before.
Of these, 40 received different doses of the vaccine, while 17 did not. They were then all exposed to the malaria-carrying mosquitoes.
The researchers found that for the participants not given any vaccine, and those given low doses, almost all became infected with malaria.
However for the small group given the highest dosage, only three of the 15 patients became infected after exposure to malaria.
Dr Robert Seder said: “Based on the history, we knew dose was important because you needed 1,000 mosquito bites to get protection – this validates that.
“It allows us in future studies to increase the dose and alter the schedule of the vaccine to further optimise it. The next critical questions will be whether the vaccine is durable over a long period of time and can the vaccine protect against other strains of malaria.”
The Latest Bing News on:
Malaria vaccine
- Monoclonal Antibody Treatment Shows Promise in Preventing Malariaon August 7, 2022 at 7:30 am
A singular injection of a monoclonal antibody treatment candidate has been shown as safe and highly protective in US adults exposed to malaria. The corresp | Drug Discovery And Development ...
- Monoclonal Antibody Prevents Malaria in Clinical Trialon August 5, 2022 at 5:00 am
Results from a Phase I clinical trial have shown that a monoclonal antibody known as L9LS is safe and highly protective in U.S. adults exposed to the malaria parasite. The use of this antibody could ...
- Lab-engineered antibody appears to protect from malaria, study showson August 4, 2022 at 11:41 am
U.S. government researchers found that a lab-engineered antibody protected most participants from infection with the malaria parasite -- including all of those who received a higher dose of the ...
- A Shot of Antibodies Could Make You Impervious to Malariaon August 3, 2022 at 2:00 pm
João P. Burini / GettyMethods for preventing malaria infections range from the low-tech, like mosquito bed nets and getting rid of standing water; to the uncannily high-tech, like genetically ...
- Malaria vaccine in clinical trials could reduce deaths by 75 percenton July 27, 2022 at 1:38 pm
Story at a glance Malaria is caused by parasites from the genus Plasmodium. The single-celled organisms are not viruses or bacteria. There’s currently one vaccine approved by the WHO for use ...
- New vaccines and global partnerships can end malaria as we know iton July 26, 2022 at 10:00 am
Before vaccines can meaningfully start helping to defeat this terrible disease, significant challenges must still be overcome.
- WHO moves to roll out first malaria vaccine in Africaon July 21, 2022 at 4:00 am
BLANTYRE, Malawi — As the World Health Organization announces the next step in its rollout of the world’s first authorized malaria vaccine in three African countries, concerns about its value ...
- WHO Moves to Roll Out First Malaria Vaccine in Africaon July 21, 2022 at 3:18 am
WHO Moves to Roll Out First Malaria Vaccine in Africa By MARIA CHENG and GREGORY GONDWE, Associated Press BLANTYRE, Malawi (AP) — As the World Health Organization announces the next step in its ...
- New way to test vaccines may be as rigorous and stringent as exposure to field strains of malariaon July 19, 2022 at 9:48 pm
Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.
- New genomic research shows why testing malaria vaccines in the clinic is as rigorous as natural exposure in the fieldon July 19, 2022 at 9:30 am
approved the world's first malaria vaccine. That vaccine reduces the incidence of malaria infections in young children aged 5-17 months by only 30 percent, meaning that it remains critical to ...
The Latest Google Headlines on:
Malaria vaccine
The Latest Bing News on:
Malaria
- Hong Kong logs 77 imported malaria infections, 2 people in serious conditionon August 8, 2022 at 4:20 am
Hong Kong has reported 77 imported malaria cases, health authorities have said. Forty-seven people are being treated at public hospitals, two of whom are in a serious condition. The city has recorded ...
- Monoclonal Antibody Treatment Shows Promise in Preventing Malariaon August 7, 2022 at 7:30 am
A singular injection of a monoclonal antibody treatment candidate has been shown as safe and highly protective in US adults exposed to malaria. The corresp | Drug Discovery And Development ...
- In the 1880s, D.C.’s doctors argued about malaria and its causeon August 6, 2022 at 9:00 am
Malaria — literally, if not scientifically, "bad air" — once claimed Washingtonians by the score. So why did some doctors believe it wasn't real?
- Monoclonal Antibody Prevents Malaria in Clinical Trialon August 5, 2022 at 5:00 am
Results from a Phase I clinical trial have shown that a monoclonal antibody known as L9LS is safe and highly protective in U.S. adults exposed to the malaria parasite. The use of this antibody could ...
- Lab-engineered antibody appears to protect from malaria, study showson August 4, 2022 at 11:41 am
U.S. government researchers found that a lab-engineered antibody protected most participants from infection with the malaria parasite -- including all of those who received a higher dose of the ...
- Monoclonal Antibody Studied for Prevention of Malariaon August 4, 2022 at 11:09 am
A next-generation antimalarial monoclonal antibody, L9LS, administered intravenously or subcutaneously, shows protective efficacy against controlled malaria infection, without evident safety concerns, ...
- Monoclonal Antibody Might Help Prevent Malariaon August 4, 2022 at 4:38 am
Researchers are reporting early but encouraging findings on a potential new way to prevent malaria — an old foe that still ranks as ...
- Monoclonal antibody prevents malaria in US adults, NIH trial showson August 3, 2022 at 5:00 pm
One injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in U.S. adults exposed to the malaria parasite, according to results from a National ...
- WHO moves to roll out first malaria vaccine in Africaon July 21, 2022 at 4:00 am
BLANTYRE, Malawi — As the World Health Organization announces the next step in its rollout of the world’s first authorized malaria vaccine in three African countries, concerns about its value ...
- New genomic research shows why testing malaria vaccines in the clinic is as rigorous as natural exposure in the fieldon July 19, 2022 at 9:30 am
Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world's first malaria vaccine.